Qin JM. Selection and clinical significance of individualized treatment for metastatic liver cancer.
Shijie Huaren Xiaohua Zazhi 2018;
26:1677-1687. [DOI:
10.11569/wcjd.v26.i29.1677]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
The liver is one of the most common target organs for metastasis of malignant tumors, with a metastasis rate of 11.1%. Approximately 40% of patients with malignant tumors will develop liver metastasis. Metastatic liver cancer not only exhibits individualized difference in the origin of primary tumor, tumor gene, and biological behavior, but also varies in the stage of progression, anatomic characteristics, organ function, and complications. In view of the different sources and pathways of metastatic tumors, the treatment of metastatic liver cancer involves two aspects: primary tumor and liver metastasis. How to choose surgery, local ablation, chemotherapy, molecular targeted drugs, endocrine therapy, biological and immune therapy, and radiotherapy as well as the treatment opportunity rationally is the key to the treatment of metastatic liver cancer. Advanced imaging techniques are used to determine the size, number, location, and blood supply of metastatic liver cancer, so as to provide an objective basis for making an accurate individualized treatment plan for metastatic liver cancer. At present, any single therapy for metastatic liver cancer has its own indications. If a metastatic liver tumor cannot be resected radically , the use of a single therapy is difficult to cure or control the progression of the tumor. In this case, it is necessary to combine two or more than two kinds of treatment methods to achieve the synergistic effect. According to the specific condition of patients with metastatic liver cancer, the individual characteristics of the patients should be analyzed by experienced clinicians to formulate an individualized treatment plan in accordance with the principles of evidence-based medicine, so as to make the patients benefit most from the plan, improve the quality of life, and prolong the survival time.
Collapse